omeprazole has been researched along with nizatidine in 37 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (2.70) | 18.7374 |
1990's | 13 (35.14) | 18.2507 |
2000's | 19 (51.35) | 29.6817 |
2010's | 4 (10.81) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Chen, CY; Chen, LT; Jan, CM; Perng, DS; Wang, WM | 1 |
Guram, M; Holt, S; Howden, CW | 1 |
Gardner, JD; Jensen, RT; Maton, PN | 1 |
Castell, DO; Just, RJ; Lagerström, PO; Leite, LP | 1 |
Bachmann, KA; Jauregui, L; Levine, L; Miller, K; Reese, J; Sullivan, TJ | 1 |
Cosentino, S; Giannone, N; Lanzafame, S; Magnano, A; Russo, A | 1 |
Chijiiwa, Y; Maruoka, A; Nawata, H; Tanaka, M | 1 |
Brummer, RJ; Stockbrügger, RW | 1 |
Berstad, A; Hatlebakk, JG | 1 |
Lee, SD; Lin, HJ; Lo, WC; Perng, CL; Wang, K | 1 |
Chan, CK; Cheung, E; Ching, TY; Chu, KM; Kong, Y; Kou, M; Kumana, CR; Lam, SK; Seto, WH | 1 |
Bertaccini, G; Coppelli, G; Coruzzi, G; Frati, P | 1 |
Itoh, M; Joh, T; Kurokawa, T; Sasakii, M; Seno, K; Tsuchida, K; Yokoyama, Y | 1 |
Furuta, S; Kamada, E; Kawabata, Y; Sano, H; Shinozaki, Y; Sugimoto, T; Suzuki, T | 1 |
Armstrong, D; Paré, P; Pericak, D; Pyzyk, M | 2 |
Andersen, LP; Chen, M; Colding, H; Jensen, B; Kharazmi, A; Kristiansen, JE; Zhai, L | 1 |
Bochenek, W; DeVault, K; Kovacs, TO; Miska, D; Wilcox, CM | 1 |
El-Serag, HB; El-Zimaity, HM; Graham, DY; Hammoud, F; Kim, JG; Osato, MS | 1 |
Armstrong, D; Goeree, R; Meyer, F; Paré, P; Pericak, D; Pyzyk, M | 1 |
Bachmann, KA; Jauregui, L; Levine, L; Miller, K; Reese, JH; Sullivan, TJ | 1 |
Fujioka, T; Kagawa, J; Kodama, M; Murakami, K; Nasu, M; Okimoto, T; Sato, R; Watanabe, K | 1 |
Bochenek, WJ; Fraga, PD; Mack, ME; Metz, DC | 1 |
Akimoto, M; Hashimoto, H; Maeda, A; Shigemoto, M; Yamashita, K | 1 |
Esplugues, JV; Martí-Cabrera, M; Ponce, J | 1 |
Eberlein, B; Gebhardt, E; Gilbertz, KP; Placzek, M; Przybilla, B | 1 |
6 review(s) available for omeprazole and nizatidine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Recent advances in the management of gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
Topics: Cimetidine; Famotidine; Gastric Acid; Histamine H2 Antagonists; Humans; Nizatidine; Omeprazole; Parasympatholytics; Ranitidine; Thiazoles; Zollinger-Ellison Syndrome | 1989 |
Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antacids; Benzimidazoles; Cimetidine; Cisapride; Domperidone; Famotidine; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Lansoprazole; Metoclopramide; Nizatidine; Omeprazole; Pantoprazole; Piperidines; Proton Pump Inhibitors; Ranitidine; Sucralfate; Sulfoxides | 1996 |
Meta-analysis: proton pump inhibitor or H2-receptor antagonist for Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Middle Aged; Nizatidine; Omeprazole; Proton Pump Inhibitors | 2003 |
Pantoprazole provides rapid and sustained symptomatic relief in patients treated for erosive oesophagitis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Antacids; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Esophagitis; Female; Gastroesophageal Reflux; Heartburn; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Nizatidine; Omeprazole; Pantoprazole; Randomized Controlled Trials as Topic; Sulfoxides; Treatment Outcome | 2004 |
[Safety of proton pump inhibitors].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Adult; Age Factors; Aged; Animals; Anti-Ulcer Agents; Cimetidine; Enzyme Inhibitors; Famotidine; Female; Fetus; Histamine H2 Antagonists; Humans; Lactation; Lansoprazole; Meta-Analysis as Topic; Nizatidine; Omeprazole; Pantoprazole; Pregnancy; Proton Pump Inhibitors; Proton-Translocating ATPases; Rabeprazole; Ranitidine; Safety; Time Factors | 2006 |
9 trial(s) available for omeprazole and nizatidine
Article | Year |
---|---|
Histologic patterns of omeprazole and nizatidine-healed duodenal ulcers:accuracy of endoscopic diagnosis.
Topics: Adult; Biopsy; Duodenal Ulcer; Duodenoscopy; Humans; Intestinal Mucosa; Middle Aged; Nizatidine; Omeprazole | 1994 |
Clarithromycin in the combination therapy for the eradication of Helicobacter pylori in peptic ulcer disease.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Middle Aged; Nizatidine; Omeprazole; Organometallic Compounds; Penicillins; Ranitidine; Salicylates | 1997 |
The therapeutic effect of proton pump inhibitors on Helicobacter pylori-positive gastric ulcers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Famotidine; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Middle Aged; Multivariate Analysis; Nizatidine; Omeprazole; Patient Dropouts; Proton Pump Inhibitors; Ranitidine; Stomach Ulcer; Treatment Outcome | 1999 |
Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Enzyme Inhibitors; Esophagitis, Peptic; Esophagoscopy; Female; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Male; Middle Aged; Nizatidine; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides | 2001 |
Comparison of the efficacy of pantoprazole vs. nizatidine in the treatment of erosive oesophagitis: a randomized, active-controlled, double-blind study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme Inhibitors; Esophagitis, Peptic; Female; Gastroesophageal Reflux; Humans; Male; Middle Aged; Nizatidine; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Severity of Illness Index; Sulfoxides; Treatment Outcome | 2002 |
Meta-analysis: proton pump inhibitor or H2-receptor antagonist for Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Middle Aged; Nizatidine; Omeprazole; Proton Pump Inhibitors | 2003 |
Validation of the GSFQ, a self-administered symptom frequency questionnaire for patients with gastroesophageal reflux disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Canada; Double-Blind Method; Female; Gastroesophageal Reflux; Humans; Male; Middle Aged; Nizatidine; Omeprazole; Pantoprazole; Quality of Life; Reproducibility of Results; Self-Assessment; Severity of Illness Index; Sulfoxides; Surveys and Questionnaires; Treatment Outcome | 2003 |
Pantoprazole rapidly improves health-related quality of life in patients with heartburn: a prospective, randomized, double blind comparative study with nizatidine.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Gastroesophageal Reflux; Health Status Indicators; Heartburn; Humans; Nizatidine; Omeprazole; Pantoprazole; Quality of Life; Sulfoxides; Treatment Outcome | 2003 |
Influence of anti-ulcer drugs used in Japan on the result of (13)C-urea breath test for the diagnosis of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Breath Tests; Carbon Radioisotopes; Dose-Response Relationship, Drug; False Negative Reactions; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Japan; Lansoprazole; Male; Middle Aged; Nizatidine; Omeprazole; Proton Pump Inhibitors; Proton Pumps; Time Factors; Treatment Outcome; Urea | 2003 |
23 other study(ies) available for omeprazole and nizatidine
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Comparison of omeprazole and nizatidine in the treatment of duodenal ulcers.
Topics: Adult; Aged; Duodenal Ulcer; Female; Gastrins; Humans; Male; Middle Aged; Nizatidine; Omeprazole | 1992 |
Further evidence for an interaction between alcohol and certain H2-receptor antagonists.
Topics: Adult; Alcoholic Intoxication; Cimetidine; Ethanol; Famotidine; Histamine H2 Antagonists; Humans; Male; Nizatidine; Omeprazole; Ranitidine | 1991 |
Control of gastric acid with high dose H2-receptor antagonists after omeprazole failure: report of two cases.
Topics: Adult; Anti-Ulcer Agents; Cimetidine; Drug Resistance; Female; Gastric Acid; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Male; Nizatidine; Omeprazole | 1995 |
Drug interactions of H2-receptor antagonists.
Topics: Adolescent; Adult; Aged; Antacids; Biological Availability; Cimetidine; Drug Interactions; Famotidine; Histamine H2 Antagonists; Humans; Middle Aged; Nizatidine; Omeprazole; Phenytoin; Ranitidine; Theophylline | 1994 |
Endoscopic ultrasonographic evaluation of gastric ulcer healing on treatment with proton pump inhibitors versus H2-receptor antagonists.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Famotidine; Female; Gastroscopy; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Middle Aged; Nizatidine; Omeprazole; Piperidines; Proton Pump Inhibitors; Stomach Ulcer; Ultrasonography, Interventional; Wound Healing | 1994 |
Effect of nizatidine 300 mg at night and omeprazole 20 mg in the morning on 24-hour intragastric pH and bacterial overgrowth in patients with acute duodenal ulcer.
Topics: Acute Disease; Adult; Aged; Anti-Ulcer Agents; Bacteria; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastric Acid; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Nizatidine; Omeprazole; Stomach | 1996 |
Antiulcer drug prescribing in hospital successfully influenced by "immediate concurrent feedback".
Topics: Administration, Oral; Anti-Ulcer Agents; Cimetidine; Cost-Benefit Analysis; Drug Utilization; Famotidine; Feedback; Hong Kong; Hospitals, Teaching; Humans; Infusions, Intravenous; Medical Audit; Nizatidine; Omeprazole; Practice Patterns, Physicians'; Ranitidine | 1998 |
Effects of different antisecretory drugs on gastric potential difference in the rat: comparison with sucralfate.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Aspirin; Drug Interactions; Gastric Acid; Lansoprazole; Male; Nizatidine; Omeprazole; Proton Pump Inhibitors; Ranitidine; Rats; Rats, Wistar; Sucralfate | 1998 |
Inhibition of drug metabolism in human liver microsomes by nizatidine, cimetidine and omeprazole.
Topics: Anti-Ulcer Agents; Cimetidine; Cytochrome P-450 Enzyme Inhibitors; Enzyme Inhibitors; Humans; In Vitro Techniques; Isoenzymes; Male; Microsomes, Liver; Nizatidine; Omeprazole; Pharmaceutical Preparations | 2001 |
Nizatidine and omeprazole enhance the effect of metronidazole on Helicobacter pylori in vitro.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Synergism; Drug Therapy, Combination; Electron Transport; Helicobacter pylori; Metronidazole; Microbial Sensitivity Tests; Nizatidine; Omeprazole | 2002 |
Absence of an inhibitory effect of omeprazole and nizatidine on phenytoin disposition, a marker of CYP2C activity.
Topics: Adult; Analysis of Variance; Anti-Ulcer Agents; Anticonvulsants; Cytochrome P-450 Enzyme System; Drug Interactions; Humans; Male; Nizatidine; Omeprazole; Phenytoin | 1993 |
Effects of antisecretory agents on angiogenesis during healing of gastric ulcers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Base Sequence; Benzimidazoles; Biopsy, Needle; Case-Control Studies; Female; Gastric Mucosa; Gastroscopy; Humans; Immunohistochemistry; Male; Middle Aged; Molecular Sequence Data; Neovascularization, Physiologic; Nizatidine; Omeprazole; Polymerase Chain Reaction; Probability; Rabeprazole; Receptors, CXCR4; Reference Values; Risk Assessment; RNA, Messenger; Severity of Illness Index; Stomach Ulcer; Wound Healing | 2005 |
In vitro evaluation of phototoxic properties of proton pump inhibitors, H2-receptor antagonists and statins.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Ascorbic Acid; Cimetidine; Erythrocytes; Famotidine; Hemolysis; Histamine H2 Antagonists; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lansoprazole; Lovastatin; Nizatidine; Omeprazole; Pantoprazole; Pravastatin; Proton Pump Inhibitors; Ranitidine; Ultraviolet Rays | 2012 |